Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 35 | 2024 | 5129 | 3.070 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 9 | 2023 | 92 | 2.150 |
Why?
|
Retroperitoneal Fibrosis | 3 | 2012 | 42 | 0.900 |
Why?
|
Neoplasms, Plasma Cell | 4 | 2024 | 39 | 0.880 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 633 | 0.670 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2023 | 5649 | 0.620 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2017 | 193 | 0.560 |
Why?
|
Myelodysplastic Syndromes | 6 | 2023 | 1392 | 0.550 |
Why?
|
Cyclophosphamide | 4 | 2024 | 2218 | 0.540 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2016 | 99 | 0.540 |
Why?
|
Paraproteinemias | 3 | 2023 | 246 | 0.520 |
Why?
|
Blood Cells | 1 | 2017 | 305 | 0.500 |
Why?
|
Chromosome Aberrations | 5 | 2023 | 1763 | 0.470 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2015 | 318 | 0.460 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3840 | 0.450 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1634 | 0.440 |
Why?
|
Arthralgia | 1 | 2016 | 461 | 0.400 |
Why?
|
Anemia | 2 | 2023 | 1504 | 0.390 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1387 | 0.390 |
Why?
|
Colitis, Microscopic | 3 | 2017 | 72 | 0.380 |
Why?
|
Osteopontin | 1 | 2012 | 301 | 0.360 |
Why?
|
Dexamethasone | 6 | 2024 | 1927 | 0.360 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2022 | 179 | 0.360 |
Why?
|
Myelodysplastic-Myeloproliferative Diseases | 2 | 2020 | 15 | 0.350 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11709 | 0.340 |
Why?
|
Myeloproliferative Disorders | 3 | 2020 | 606 | 0.340 |
Why?
|
Immunologic Factors | 1 | 2018 | 1585 | 0.330 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2021 | 646 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8506 | 0.320 |
Why?
|
Thrombocytopenia | 3 | 2024 | 1171 | 0.310 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6493 | 0.310 |
Why?
|
Prognosis | 19 | 2024 | 29557 | 0.310 |
Why?
|
GTP Phosphohydrolases | 2 | 2022 | 517 | 0.300 |
Why?
|
Lymphoma | 1 | 2017 | 1896 | 0.300 |
Why?
|
Knee Joint | 1 | 2016 | 1663 | 0.290 |
Why?
|
Proto-Oncogene Proteins | 4 | 2021 | 4485 | 0.290 |
Why?
|
Dioxygenases | 4 | 2023 | 332 | 0.290 |
Why?
|
Transplantation, Autologous | 6 | 2023 | 2114 | 0.290 |
Why?
|
Renal Insufficiency | 2 | 2023 | 809 | 0.280 |
Why?
|
Cytogenetic Analysis | 4 | 2022 | 270 | 0.280 |
Why?
|
Mutation | 11 | 2023 | 29915 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2825 | 0.260 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2023 | 2504 | 0.260 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2023 | 3599 | 0.260 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58683 | 0.260 |
Why?
|
Calcium | 2 | 2015 | 5721 | 0.250 |
Why?
|
Aged | 35 | 2024 | 168218 | 0.250 |
Why?
|
Leukocyte Count | 3 | 2018 | 1593 | 0.250 |
Why?
|
Middle Aged | 37 | 2024 | 219568 | 0.240 |
Why?
|
Humans | 81 | 2024 | 758406 | 0.240 |
Why?
|
Mononeuropathies | 1 | 2023 | 13 | 0.220 |
Why?
|
Plasmacytoma | 1 | 2023 | 171 | 0.210 |
Why?
|
Male | 41 | 2024 | 358747 | 0.210 |
Why?
|
Scleroderma, Systemic | 2 | 2019 | 344 | 0.210 |
Why?
|
Leukemia | 2 | 2021 | 1519 | 0.200 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1007 | 0.200 |
Why?
|
Cytokines | 1 | 2017 | 7338 | 0.200 |
Why?
|
Survival Analysis | 5 | 2022 | 10112 | 0.200 |
Why?
|
Rickets | 1 | 2022 | 71 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2022 | 87 | 0.190 |
Why?
|
Hypercalcemia | 1 | 2024 | 421 | 0.180 |
Why?
|
Repressor Proteins | 2 | 2022 | 2980 | 0.180 |
Why?
|
Doxycycline | 1 | 2022 | 341 | 0.180 |
Why?
|
Lymphocytes | 2 | 2018 | 2610 | 0.170 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4158 | 0.170 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2019 | 70 | 0.170 |
Why?
|
Thrombocytosis | 1 | 2020 | 81 | 0.170 |
Why?
|
Primary Myelofibrosis | 1 | 2022 | 208 | 0.170 |
Why?
|
Immunoglobulin Light Chains | 2 | 2024 | 286 | 0.170 |
Why?
|
Retrospective Studies | 22 | 2024 | 80168 | 0.170 |
Why?
|
DNA-Binding Proteins | 4 | 2023 | 9574 | 0.170 |
Why?
|
Bone Diseases | 1 | 2023 | 419 | 0.160 |
Why?
|
Anemia, Sideroblastic | 1 | 2020 | 109 | 0.160 |
Why?
|
Bone Marrow Cells | 2 | 2024 | 2414 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 238 | 0.160 |
Why?
|
Antibodies, Monoclonal | 4 | 2024 | 9160 | 0.160 |
Why?
|
Female | 35 | 2024 | 390323 | 0.160 |
Why?
|
Adult | 25 | 2024 | 219935 | 0.160 |
Why?
|
Sarcopenia | 1 | 2023 | 372 | 0.160 |
Why?
|
Monocytes | 2 | 2018 | 2570 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1326 | 0.160 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.160 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3754 | 0.160 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 300 | 0.160 |
Why?
|
Minnesota | 1 | 2019 | 338 | 0.150 |
Why?
|
Epistasis, Genetic | 1 | 2020 | 350 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.150 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 350 | 0.150 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2020 | 685 | 0.150 |
Why?
|
Survival Rate | 7 | 2022 | 12721 | 0.150 |
Why?
|
Azacitidine | 1 | 2019 | 334 | 0.140 |
Why?
|
Hemostasis, Surgical | 1 | 2018 | 127 | 0.140 |
Why?
|
Epigenomics | 1 | 2023 | 936 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13591 | 0.140 |
Why?
|
Hematinics | 1 | 2020 | 280 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 372 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 677 | 0.140 |
Why?
|
Flow Cytometry | 2 | 2024 | 5864 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2019 | 778 | 0.140 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 192 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1826 | 0.130 |
Why?
|
SEER Program | 1 | 2021 | 1530 | 0.130 |
Why?
|
Thromboembolism | 1 | 2023 | 996 | 0.130 |
Why?
|
Lichen Planus | 1 | 2016 | 71 | 0.130 |
Why?
|
Bone Marrow | 4 | 2022 | 2909 | 0.130 |
Why?
|
Esophageal Diseases | 1 | 2016 | 168 | 0.130 |
Why?
|
RNA Splicing | 1 | 2020 | 913 | 0.130 |
Why?
|
Receptors, Interleukin-2 | 1 | 2017 | 562 | 0.130 |
Why?
|
Budesonide | 1 | 2016 | 158 | 0.130 |
Why?
|
Polyploidy | 1 | 2016 | 119 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2022 | 6821 | 0.130 |
Why?
|
Neoplasm Staging | 3 | 2022 | 11152 | 0.130 |
Why?
|
Glucocorticoids | 2 | 2016 | 2144 | 0.120 |
Why?
|
Histocompatibility | 1 | 2016 | 316 | 0.120 |
Why?
|
Risk Factors | 10 | 2024 | 73809 | 0.120 |
Why?
|
ras Proteins | 1 | 2020 | 1049 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2022 | 7843 | 0.120 |
Why?
|
Clinical Medicine | 1 | 2015 | 145 | 0.120 |
Why?
|
Disease Progression | 6 | 2024 | 13468 | 0.120 |
Why?
|
Age Factors | 4 | 2020 | 18358 | 0.110 |
Why?
|
Stem Cell Transplantation | 4 | 2023 | 1599 | 0.110 |
Why?
|
Treatment Outcome | 13 | 2023 | 64378 | 0.110 |
Why?
|
Drug Resistance | 1 | 2019 | 1593 | 0.110 |
Why?
|
Disease Management | 2 | 2021 | 2500 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12440 | 0.110 |
Why?
|
Diarrhea | 2 | 2017 | 1317 | 0.110 |
Why?
|
Mortality | 2 | 2021 | 2886 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 58808 | 0.100 |
Why?
|
Embryonic Development | 1 | 2017 | 716 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1377 | 0.100 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11336 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39059 | 0.100 |
Why?
|
Cell Movement | 1 | 2024 | 5201 | 0.100 |
Why?
|
Dendritic Cells | 2 | 2020 | 2723 | 0.100 |
Why?
|
Immunoglobulin A | 1 | 2015 | 979 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15785 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1840 | 0.100 |
Why?
|
Prednisone | 1 | 2016 | 1565 | 0.100 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2018 | 867 | 0.100 |
Why?
|
Genotype | 2 | 2016 | 12945 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2022 | 1277 | 0.090 |
Why?
|
Chemokines, CC | 1 | 2012 | 283 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2012 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1110 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2717 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7590 | 0.090 |
Why?
|
Drug Evaluation | 1 | 2011 | 638 | 0.090 |
Why?
|
C-Reactive Protein | 2 | 2019 | 3812 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2457 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3442 | 0.080 |
Why?
|
Hemoglobins | 1 | 2015 | 1519 | 0.080 |
Why?
|
Endometriosis | 1 | 2017 | 874 | 0.080 |
Why?
|
Alleles | 2 | 2020 | 6895 | 0.080 |
Why?
|
Gene Expression | 1 | 2022 | 7583 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2017 | 1996 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8530 | 0.080 |
Why?
|
Colon | 1 | 2017 | 1787 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 2929 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1890 | 0.080 |
Why?
|
Leukemia, Myeloid | 2 | 2021 | 695 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3609 | 0.070 |
Why?
|
Odds Ratio | 2 | 2018 | 9650 | 0.070 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16886 | 0.070 |
Why?
|
Lung Diseases | 2 | 2018 | 1910 | 0.070 |
Why?
|
Prostatectomy | 1 | 2015 | 1956 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 15773 | 0.070 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2528 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9273 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3801 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 39872 | 0.060 |
Why?
|
Remission Induction | 2 | 2022 | 2388 | 0.060 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2189 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 16534 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2037 | 0.060 |
Why?
|
Chronic Disease | 2 | 2017 | 9267 | 0.060 |
Why?
|
Logistic Models | 2 | 2016 | 13276 | 0.060 |
Why?
|
Cytogenetics | 1 | 2024 | 198 | 0.060 |
Why?
|
Up-Regulation | 1 | 2012 | 4113 | 0.050 |
Why?
|
Risk Assessment | 3 | 2020 | 23884 | 0.050 |
Why?
|
RNA, Small Nuclear | 1 | 2023 | 74 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2023 | 2047 | 0.050 |
Why?
|
Bone Marrow Examination | 1 | 2022 | 154 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18119 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12094 | 0.050 |
Why?
|
Leukocytosis | 1 | 2023 | 251 | 0.050 |
Why?
|
Melphalan | 1 | 2023 | 420 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12876 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7378 | 0.050 |
Why?
|
Neoplasms | 2 | 2020 | 22032 | 0.050 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2022 | 200 | 0.050 |
Why?
|
Genes, myc | 1 | 2021 | 391 | 0.040 |
Why?
|
Metaphase | 1 | 2020 | 144 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6548 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5797 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10718 | 0.040 |
Why?
|
Penicillins | 1 | 2022 | 406 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14641 | 0.040 |
Why?
|
Proteinuria | 1 | 2022 | 594 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2023 | 475 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2020 | 473 | 0.040 |
Why?
|
Myeloma Proteins | 1 | 2018 | 71 | 0.040 |
Why?
|
Melena | 1 | 2018 | 32 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2021 | 859 | 0.040 |
Why?
|
Hematemesis | 1 | 2018 | 22 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1529 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2020 | 876 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2640 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2018 | 203 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 886 | 0.030 |
Why?
|
United States | 2 | 2022 | 72136 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1588 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15225 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2020 | 682 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41256 | 0.030 |
Why?
|
Defecation | 1 | 2016 | 190 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13285 | 0.030 |
Why?
|
Prospective Studies | 2 | 2016 | 54137 | 0.030 |
Why?
|
Platelet Transfusion | 1 | 2018 | 294 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 697 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36284 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9051 | 0.030 |
Why?
|
Child, Preschool | 3 | 2023 | 42062 | 0.030 |
Why?
|
Fecal Incontinence | 1 | 2016 | 241 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1312 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1632 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2004 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2018 | 563 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3574 | 0.030 |
Why?
|
Oocytes | 1 | 2017 | 1165 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4809 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2634 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4106 | 0.020 |
Why?
|
Hypotension | 1 | 2018 | 879 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3527 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2433 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 759 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 87892 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2016 | 625 | 0.020 |
Why?
|
E-Selectin | 1 | 2013 | 576 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6520 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1368 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 691 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2016 | 1063 | 0.020 |
Why?
|
Feces | 1 | 2016 | 1456 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1887 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3521 | 0.020 |
Why?
|
Fertilization in Vitro | 1 | 2017 | 1292 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2379 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3615 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9599 | 0.020 |
Why?
|
Colonoscopy | 1 | 2017 | 1388 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1632 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4902 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9518 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3283 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23342 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10748 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36055 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2018 | 1930 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6354 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3675 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6768 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7016 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 1892 | 0.020 |
Why?
|
Aortic Diseases | 1 | 2012 | 735 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14354 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8426 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9404 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3563 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20055 | 0.020 |
Why?
|
Genomics | 1 | 2020 | 5790 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81101 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2018 | 3732 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10416 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14490 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3024 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10495 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22003 | 0.010 |
Why?
|
Child | 2 | 2020 | 79818 | 0.010 |
Why?
|
Animals | 2 | 2022 | 167768 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22029 | 0.010 |
Why?
|